StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
8
Publishing Date
2024 - 03 - 15
9
2024 - 03 - 11
13
2024 - 03 - 04
11
2024 - 02 - 20
9
2024 - 02 - 13
9
2024 - 02 - 12
10
2024 - 01 - 08
10
2023 - 12 - 18
9
2023 - 12 - 07
9
2023 - 11 - 27
11
2023 - 10 - 31
10
2023 - 10 - 26
10
2023 - 10 - 02
11
2023 - 09 - 18
9
2023 - 09 - 12
9
2023 - 09 - 11
11
2023 - 09 - 06
10
2023 - 08 - 15
10
2023 - 08 - 01
10
2023 - 06 - 22
9
2023 - 05 - 01
15
2023 - 04 - 24
9
2023 - 03 - 08
10
2023 - 01 - 19
9
2022 - 12 - 22
9
2022 - 12 - 20
10
2022 - 10 - 06
9
2022 - 07 - 19
9
2022 - 07 - 11
9
2022 - 07 - 05
9
2022 - 05 - 31
14
2022 - 05 - 24
10
2022 - 05 - 02
10
2022 - 01 - 31
11
2022 - 01 - 18
16
2021 - 12 - 22
9
2021 - 12 - 21
12
2021 - 12 - 20
10
2021 - 12 - 09
11
2021 - 12 - 01
13
2021 - 11 - 30
10
2021 - 11 - 29
10
2021 - 11 - 01
12
2021 - 09 - 28
9
2021 - 09 - 20
11
2021 - 08 - 24
9
2021 - 07 - 29
10
2021 - 07 - 06
10
2021 - 06 - 29
9
2021 - 06 - 11
17
2021 - 06 - 01
13
2021 - 05 - 28
10
2021 - 04 - 21
10
2021 - 04 - 19
10
2021 - 04 - 13
8
2021 - 04 - 12
9
2021 - 03 - 01
8
2021 - 02 - 01
8
2021 - 01 - 19
8
2020 - 12 - 17
11
Sector
Commercial services
1
Health technology
5
Professional, scientific, and technical services
1
Tags
Alzheimer
3
Alzheimer's
3
Alzheimer’s
3
Antibody
4
Application
8
Approval
6
Biocapital
4
Bioscience
3
Biotech
4
Breast cancer
3
Cancer
7
Cell carcinoma
4
Ceo
3
Clinical-trials-phase-ii
6
Clinical-trials-phase-iii
5
Collaboration
6
Commercialization
3
Conference
37
Covid
11
Covid-19
3
Designation
5
Device
3
Disease
5
Distribution
4
Drug
4
Energy
10
Enroll
4
Europe
9
Ev
3
Expansion
6
Fda
8
Financial results
7
Growth
13
Health
5
Hotel
4
Iot
8
Leo
4
Merge
5
N/a
312
Offering
15
Partnership
4
People
11
Pharm-country
5
Phase 2
11
Phase 3
8
Positive
8
Presentation
12
Program
7
Research
23
Results
20
Set
4
Software
5
Spac
4
Space
4
Technology
12
Test
4
Therapy
8
Treatment
8
Trial
21
Vaccine
7
Entities
Astrazeneca plc
1
Biogen inc.
1
Bluebird bio, inc.
1
Cullinan management inc
1
Medtronic plc
1
Novo nordisk a/s
1
Opgen, inc.
1
Synaptogenix inc
1
Symbols
AZN
1
BIIB
1
BLUE
1
CGEM
1
MDT
1
NVO
1
OPGN
1
SNPX
1
Exchanges
Nasdaq
6
Nyse
2
Crawled Date
2021 - 06 - 07
8
Crawled Time
12:00
1
13:00
3
14:00
1
16:00
1
18:00
1
19:00
1
Source
www.biospace.com
5
www.globenewswire.com
2
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2021 - 06 - 07
tags :
Fda
save search
Alexion Announces FDA Approval of ULTOMIRIS® (ravulizumab-cwvz) for Children and Adolescents with Paroxysmal Nocturnal Hemoglobinuria (PNH)
Published:
2021-06-07
(Crawled : 19:00)
- biospace.com/
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
20.18%
|
O:
-0.32%
H:
0.6%
C:
-0.39%
fda
fda approval
children
approval
FDA grants accelerated approval for ADUHELM™ as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease
Published:
2021-06-07
(Crawled : 18:00)
- globenewswire.com
BIIB
|
$190.55
-0.84%
-0.84%
1.5M
|
Health Technology
|
-31.8%
|
O:
3.22%
H:
58.64%
C:
34.03%
disease
alzheimer
treatment
fda
approval
alzheimer’s
alzheimer's disease
alzheimer's
Synaptogenix Responds to FDA Approval of Aducanumab
Published:
2021-06-07
(Crawled : 16:00)
- prnewswire.com
SNPX
|
$4.66
-2.92%
-3.0%
42K
|
Professional, Scientific, and T...
|
-31.03%
|
O:
7.76%
H:
26.67%
C:
-8.67%
fda
fda approval
approval
FDA Approves First-of-its-Kind SenSight™ Directional Lead System for DBS Therapy
Published:
2021-06-07
(Crawled : 14:00)
- biospace.com/
MDT
|
$79.19
0.14%
0.0%
6.1M
|
Health Technology
|
-36.15%
|
O:
0.44%
H:
0.6%
C:
-0.35%
fda
therapy
fda approval
approval
BioCelerate Continues to Help Improve Nonclinical Study Operations through Public Private Partnership with the FDA
Published:
2021-06-07
(Crawled : 13:00)
- biospace.com/
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
53.84%
|
O:
0.59%
H:
0.59%
C:
-0.28%
fda
partnership
Cullinan Oncology Receives Investigational New Drug (IND) Clearance from the FDA for CLN-049, a FLT3 x CD3 Bispecific Antibody for the Treatment of Relapsed/Refractory AML
Published:
2021-06-07
(Crawled : 13:00)
- biospace.com/
CGEM
|
$18.06
1.01%
1.0%
700K
|
|
-47.69%
|
O:
0.27%
H:
4.48%
C:
1.99%
new drug
treatment
fda
antibody
drug
clearance
aml
bluebird bio Announces the Lifting of FDA Clinical Hold for Sickle Cell Disease and β-Thalassemia Studies
Published:
2021-06-07
(Crawled : 13:00)
- biospace.com/
BLUE
|
$0.9583
-0.52%
-0.52%
6.5M
|
Health Technology
|
-96.93%
|
O:
4.85%
H:
0.46%
C:
-1.36%
disease
fda
clinical hold
OpGen Submits Updated 510(k) Summary to FDA and Successfully Completes Move to New Headquarters in Maryland
Published:
2021-06-07
(Crawled : 12:00)
- globenewswire.com
OPGN
A
|
$0.581
-3.15%
-3.25%
200K
|
Commercial Services
|
-70.05%
|
O:
2.42%
H:
7.4%
C:
5.66%
fda
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.